Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 16, 2024LeukemiaOpen Access

Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

TJTomáš Jelı́nekDŽDavid ŽihalaTŠTereza Ševčíková

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jelı́nek et al. (2024) studied this question.

synapsesocial.com/papers/68e73b88b6db6435876b4e8dhttps://doi.org/10.1038/s41375-024-02206-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma2022 · 42 citations
  2. 2First results from the RedirecTT-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting BCMA and GPRC5D in patients (pts) with relapsed/refractory multiple myeloma (RRMM).2023 · 89 citations
  3. 3The urgent need to recover MHC class I in cancers for effective immunotherapy2016 · 586 citations
  4. 4The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma2019 · 219 citations
  5. 5Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse2013 · 187 citations